Ora, Inc websites use cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and their use, please see our Privacy Policy.
Study comparing the effectiveness of an allergy eye drop to an allergy nasal spray in reducing eye itching associated with allergies.
Currently Enrolling
This study involves up to 5 visits over the course of approximately 5 weeks.
If you complete up to 5 visits, you will be compensated up to $450 for your time. If you do not qualify or complete all visits, you may be paid for each visit that you come into the office for.
Andover, MA
There are no other locations for this study.
This study is intended for participants who have a history of eye allergies (and a positive reaction to an allergy skin test). Common symptoms of ocular allergies include eye itching, redness, and watering, as well as swollen eyelids and blurred vision. These symptoms can affect one eye or both eyes and can be caused by environmental allergies (IE. Pollen or grass) or year-round allergies (IE. Pet dander or dust).
This study will be evaluating the effectiveness of Pataday® Once Daily Relief Extra Strength eye drop compared to Flonase® Allergy Relief nasal spray in reducing eye itching associated with allergies. Both the eye drop, and nasal spray are already approved by the United States Food and Drug Administration (FDA).
Key Inclusion Criteria
Key Exclusion Criteria
Sign up for email alerts when new trials and locations are added for a medical condition.